Date | Acquired company | Acquiring company | Amount | Related |
---|---|---|---|---|
2013-02-21 | AROS Applied Biotechnology (Denmark) | Eurofins Scientific (Luxembourg) | Genomic services |
|
2013-02-04 | clinical trial services division of Cross Country Healthcare (USA) | Icon (Ireland) | $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones | clinical research |
2013-02-01 | Confarma | Solvias (Switzerland) | undisclosed | analytical services |
2013-01-25 | Pierrel Research International (Contract Research Organization of Pierrel - Italy) | mondoBIOTECH (Switzerland) | Clinical research |
|
2013-01-15 | Cangenix (UK) | Galapagos (Belgium) | £1 million, with a further £440,000 potential earn out payment contingent upon achievement of certain conditions | Services |
2013-01-08 | Lotus Tissue Repair (USA) | Shire (UK - USA) | undisclosed (upfront payment and certain contingent payments based on the achievement of certain safety and development milestones) | Rare diseases |
2013-01-08 | Aureus Sciences (France) | Elsevier (The Netherlands) | undisclosed | Databases |
2013-01-04 | U.S. Animal Health Business From Teva Pharmaceutical Industries (Israel) | Bayer (Germany) | $ 145 million (€ 110.45 million) | Animal healthcare |
2013-01-03 | Cell Culture Service (Germany) | Evotec (Germany) | €1.15 million plus an earn-out payment dependent on business Performance | services |
2013-01-02 | Quotient Bioresearch's Bioanalytical Sciences division (UK) | LGC Standards (UK) | undisclosed | Bioanalytical services |
2012-12-26 | CV Ingenuity (USA) | Covidien (Ireland) | undisclosed | Medical devices |
2012-12-21 | Cerep (France) | Eurofins Scientific (Luxembourg) | € 25.2 million | services |
2012-12-21 | minority share in Karolinska Development’s holdings in 13 of its 25 portfolio companies | Rosetta Capital (UK) | SEK 220 million (€25.5 million) | |
2012-12-20 | Dosch Pharmaceuticals (India) | Merial, a Sanofi company (France) | Financial details were not disclosed. | Veterinary medicine |
2012-12-20 | Dendreon's manufacturing facility (USA - NJ) | Novartis (Switzerland) | $43 million (€32.5 million) | Manufacturing |
2012-12-19 | Harrison Clinical Research (Germany) | Synteract (USA) | undisclosed | CRO |
2012-12-17 | NeuroNova (Sweden) | Newron (Italy) | €16 million | Neurodegenerative diseases |
2012-12-16 | AbD Serotec, MorphoSys's Research and Diagnostic Antibody Business (Germany) | Bio-Rad (USA) | € 53 million | diagnostic |
2012-12-16 | Intercell (Austria) | Vivalis (France) | €133 million | vaccines |
2012-12-14 | portfolio of Lundbeck’s (Denmark) non-core products primarily related to the United States | Recordati (Italy) | up to $100 million (€76 million) | drug industry |